GenSight Biologics shares resume trading today
Over €9.2 million offering of ABSA composed of a reserved offering aimed at specialized investors and a private placement
More than 50% of the.
Nosopharm welcomes new members to supervisory board pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
The market value of the volume of Estonia's stabilization reserve shrank by €3.6 million in the last year to land on €428 million in March, a finance ministry report suggests.
16.02.2022 - Regulatory News: Aelis Farma (Paris: AELIS), a clinical-stage biopharmaceutical company specializing in the development of treatments for brain diseases (the Company ), announces today the successful completion of its initial public offering on .
Capital increase of approximately €25 million, i.e. 100% of the initial objective, despite high market volatility Size of the transaction which may be increased to approximately €25.55 million